logo

Sesen Bio Inc (SESN)



Trade SESN now with
  Date
  Headline
12/9/2019 7:32:51 AM Sesen Bio Initiates Rolling Submission Of BLA For Vicinium To FDA
11/12/2019 7:14:33 AM Sesen Bio Q3 Net Loss $13.1 Mln Or $0.13/Shr Vs Loss $14.0 Mln Or $0.18/Shr Last Year
6/19/2019 8:17:31 AM Sesen Bio Reports Pricing Of Public Offering Of 20.4 Mln Shares Of Common Stock And Warrants
1/3/2019 6:33:24 AM Sesen Bio Announces Positive Preliminary 12-Month Data From Registration Phase 3 VISTA Trial Of Vicinium For NMIBC
12/26/2018 12:40:01 AM 8 Biotech Stocks To Watch This Week
12/3/2018 6:30:52 AM Sesen Bio Appoints Dennis Kim As Chief Medical Officer
8/14/2018 6:33:49 AM Sesen Bio Q2 Net Loss $9.0 Mln Or $0.16/Shr Vs Loss $7.3 Mln Or $0.30/Shr Last Year
8/9/2018 6:32:03 AM Sesen Bio Says FDA Granted Fast Track Designation To Vicinium
6/4/2018 4:02:28 PM Sesen Bio Announces Closing Of Public Offering Of Common Stock
6/1/2018 6:37:10 AM In The Spotlight: Sesen Bio
5/30/2018 9:36:25 PM Sesen Bio Prices Underwritten Public Offering Of 22.22 Mln Shares At $1.80/shr
  
 
>